Presentation TCT 2016 Possible Approval Pathways for New Mitral and Tricuspid Valve Therapies Presenter: John C Laschinger November 01, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Mitral Valve Up Next Presentation TCT 2016 "DCB Efficacy In the SFA: Class-Effect or Device Specific" Presenter: Salvatore Cassese November 01, 2016 More slides + Presentation TCT 2016 Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened? Presenter: Gregg W. Stone November 01, 2016 Presentation TCT 2016 Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world" Presenter: Koen Deloose November 01, 2016 We Recommend
Presentation TCT 2016 "DCB Efficacy In the SFA: Class-Effect or Device Specific" Presenter: Salvatore Cassese November 01, 2016
Presentation TCT 2016 Learnings From A Pivotal Transcatheter Mitral Device Trial: Can The MVARC/COAPT Paradigm Be Shortened? Presenter: Gregg W. Stone November 01, 2016
Presentation TCT 2016 Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world" Presenter: Koen Deloose November 01, 2016